March 2, 2017 -- The enteral stents market across the North American countries of Canada, Mexico, and the US is set to grow from around $46.8 million in 2016 to $62.3 million by 2023, representing a compound annual growth rate (CAGR) of 4.2%, according to research and consulting firm GlobalData.
The company’s latest report states that the enteral stents space, which includes esophageal stents, gastrointestinal stents, and colonic stents, will primarily be driven by increased cancer rates, greater prevalence of diseases such as diabetes and obesity, and the development of stenting technology.
Brigitte Babin, MSc, Healthcare Analyst for GlobalData, explains: “The US is the largest enteral stent market globally and is expected to remain so throughout the forecast period, with an anticipated rise from $42.7 million in 2016 to around $57 million by 2023, at a CAGR of 4.2%. In terms of market segmentation, fully covered enteral stents dominate the space with a 73% share in 2016, followed by partially covered enteral stents.
Ad Statistics
Times Displayed: 348574
Times Visited: 21068 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
“While all esophageal stents were originally uncovered, partially covered and fully covered stents have become more common, as covering helps to combat the complication of tumor and tissue ingrowth. Indeed, the fully covered and partially covered stents market segments are both increasing in North America, with a combined CAGR of 4.7% in the US, while the non-covered stents market is decreasing in all countries within the region.”
There are three key players in the international enteral stents market. Boston Scientific is the leading company in the space market thanks to an extensive product line and a presence in all segments. Its presence was further strengthened by the acquisition of EndoChoice, a former smaller player in the enteral stents market.
The other two key players in the enteral stent market are Cook Medical and Taewoong Medical. Cook Medical has established a strong presence despite a small product line, while Taewoong Medical has a more extensive product portfolio.
About GlobalData
4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology and professional services sectors.
Back to HCB News
